Full Text:
<2334>
Summary: 
<1645>
CLC number: R758.25
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2017-06-16
Cited: 0
Clicked: 3783
Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma
| ||||||||||||||
Yuan Liang, Zhou Yang, Zi-gang Xu, Lin Ma. Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma[J]. Journal of Zhejiang University Science B, 2017, 18(7): 649-652.
@article{title="Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma",
author="Yuan Liang, Zhou Yang, Zi-gang Xu, Lin Ma",
journal="Journal of Zhejiang University Science B",
volume="18",
number="7",
pages="649-652",
year="2017",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1700065"
}
%0 Journal Article
%T Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma
%A Yuan Liang
%A Zhou Yang
%A Zi-gang Xu
%A Lin Ma
%J Journal of Zhejiang University SCIENCE B
%V 18
%N 7
%P 649-652
%@ 1673-1581
%D 2017
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1700065
TY - JOUR
T1 - Toxic epidermal necrolysis after dactinomycin and vincristine combination chemotherapy for nephroblastoma
A1 - Yuan Liang
A1 - Zhou Yang
A1 - Zi-gang Xu
A1 - Lin Ma
J0 - Journal of Zhejiang University Science B
VL - 18
IS - 7
SP - 649
EP - 652
%@ 1673-1581
Y1 - 2017
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1700065
Abstract: In this study, we describe a 2-year-old boy patient with nephroblastoma who has developed toxic epidermal necrolysis (TEN) associated with the combination chemotherapy administration of dactinomycin and vincristine. A skin biopsy confirmed the diagnosis of TEN, and with methylprednisolone pulse therapy, intravenous immunoglobulin (IVIG), and supportive care, the patient improved significantly.
[1]Aznab, M., Khazaei, M., 2016. Stevens-Johnson syndrome patient received combination chemotherapy gemcitabine, cisplatin, and 5-FU for biliary tract cancer. Int. J. Cancer Manag., 9(3):e4211.
[2]Chung, W.H., Wang, C.W., Dao, R.L., 2016. Severe cutaneous adverse drug reactions. J. Dermatol., 43(7):758-766.
[3]Gravante, G., Delogu, D., Marianetti, M., et al., 2007. Toxic epidermal necrolysis and Steven-Johnson syndrome in oncologic patients. Eur. Rev. Med. Pharmacol. Sci., 11(4):269-274.
[4]Hockett, K.C., 2004. Stevens-Johnson syndrome and toxic epidermal necrolysis: oncologic considerations. Clin. J. Oncol. Nurs., 8(1):27-55.
[5]Jones, R., Kirkup, M., Guglani, S., et al., 2006. Toxic epidermal necrolysis after PCV combination chemotherapy for relapsed B-cell lymphoma. Clin. Oncol. (R. Coll. Radiol.), 18(1):90.
[6]Schoeffler, A., Levy, E., Weinborn, M., et al., 2014. Stevens-Johnson syndrome and Hodgkin’s disease: a fortuitous association or paraneoplastic syndrome? Ann. Dermatol. Venereol., 141(2):134-140 (in French).
[7]Schwartz, R.A., McDonough, P.H., Lee, B.W., 2013. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J. Am. Acad. Dermatol., 69(2):173.e1-173.e13; quiz 185-186.
[8]Wu, J., Lee, Y.Y., Su, S.C., et al., 2015. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with malignancies. Br. J. Dermatol., 173(5):1224-1231.
[9]Yang, C.H., Yang, L.J., Jaing, T.H., et al., 2000. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole. Int. J. Dermatol., 39(8):621-623.
[10]Yoshifuku, K., Nishimoto, K., Matsuzaki, T., et al., 2015. A case of Stevens-Johnson syndrome developing during chemoradiotherapy for maxillary sinus cancer. Nihon Jibiinkoka Gakkai Kaiho, 118(12):1436-1442 (in Japanese).
ORCID: 
Open peer comments: Debate/Discuss/Question/Opinion
<1>